Hims & Hers Health, Inc. (HIMS) Misses Q4 EPS by 6c, Revenue Beats, Offers Guidance

Hims & Hers Health, Inc. (NYSE: HIMS) reported Q4 EPS of $0.11, $0.06 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $481.1 million versus the consensus estimate of $469.33 million.

GUIDANCE:

Hims & Hers Health, Inc. sees FY2025 revenue of $2.3-2.4 billion, versus the consensus of $2.09 billion.

• Adjusted EBITDA of $270 million to $320 million, reflecting an Adjusted EBITDA margin of 12% to 13%.

Hims & Hers Health, Inc. sees Q1 2025 revenue of $520-540 million, versus the consensus of $482.5 million.

• Adjusted EBITDA of $55 million to $65 million, reflecting an Adjusted EBITDA margin of 11% to 12%.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.

You May Also Be Interested In

• What Delta’s report tells investors in American and United
• The Simply Goods Group (SMPL) PT Raised to $15 at UBS Following Q3 Earnings
• Delta Air Lines stock climbs on earnings beat and strong guidance